ID   KPCT_RAT                Reviewed;         707 AA.
AC   Q9WTQ0;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 2.
DT   07-APR-2021, entry version 141.
DE   RecName: Full=Protein kinase C theta type;
DE            EC=2.7.11.13 {ECO:0000250|UniProtKB:Q04759};
DE   AltName: Full=nPKC-theta;
GN   Name=Prkcq; Synonyms=Pkcq;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 524-667.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=11220785; DOI=10.1385/jmn:15:2:121;
RA   Minami H., Owada Y., Suzuki R., Handa Y., Kondo H.;
RT   "Localization of mRNAs for novel, atypical as well as conventional protein
RT   kinase C (PKC) isoforms in the brain of developing and mature rats.";
RL   J. Mol. Neurosci. 15:121-135(2000).
RN   [3]
RP   FUNCTION IN PHOSPHORYLATION OF MSN.
RX   PubMed=9516463; DOI=10.1074/jbc.273.13.7594;
RA   Pietromonaco S.F., Simons P.C., Altman A., Elias L.;
RT   "Protein kinase C-theta phosphorylation of moesin in the actin-binding
RT   sequence.";
RL   J. Biol. Chem. 273:7594-7603(1998).
RN   [4]
RP   INTERACTION WITH GLRX3.
RX   PubMed=18479680; DOI=10.1016/j.cellimm.2008.04.005;
RA   Kato N., Motohashi S., Okada T., Ozawa T., Mashima K.;
RT   "PICOT, protein kinase C theta-interacting protein, is a novel regulator of
RT   FcepsilonRI-mediated mast cell activation.";
RL   Cell. Immunol. 251:62-67(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-676, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-
CC       dependent serine/threonine-protein kinase that mediates non-redundant
CC       functions in T-cell receptor (TCR) signaling, including T-cells
CC       activation, proliferation, differentiation and survival, by mediating
CC       activation of multiple transcription factors such as NF-kappa-B, JUN,
CC       NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required
CC       for the activation of NF-kappa-B and JUN, which in turn are essential
CC       for IL2 production, and participates in the calcium-dependent NFATC1
CC       and NFATC2 transactivation. Mediates the activation of the canonical
CC       NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11 on
CC       several serine residues, inducing CARD11 association with lipid rafts
CC       and recruitment of the BCL10-MALT1 complex, which then activates IKK
CC       complex, resulting in nuclear translocation and activation of NFKB1.
CC       May also play an indirect role in activation of the non-canonical NF-
CC       kappa-B (NFKB2) pathway. In the signaling pathway leading to JUN
CC       activation, acts by phosphorylating the mediator STK39/SPAK and may not
CC       act through MAP kinases signaling. Plays a critical role in TCR/CD28-
CC       induced NFATC1 and NFATC2 transactivation by participating in the
CC       regulation of reduced inositol 1,4,5-trisphosphate generation and
CC       intracellular calcium mobilization. After costimulation of T-cells
CC       through CD28 can phosphorylate CBLB and is required for the
CC       ubiquitination and subsequent degradation of CBLB, which is a
CC       prerequisite for the activation of TCR. During T-cells differentiation,
CC       plays an important role in the development of T-helper 2 (Th2) cells
CC       following immune and inflammatory responses, and, in the development of
CC       inflammatory autoimmune diseases, is necessary for the activation of
CC       IL17-producing Th17 cells. May play a minor role in Th1 response. Upon
CC       TCR stimulation, mediates T-cell protective survival signal by
CC       phosphorylating BAD, thus protecting T-cells from BAD-induced
CC       apoptosis, and by up-regulating BCL-X(L)/BCL2L1 levels through NF-
CC       kappa-B and JUN pathways. In platelets, regulates signal transduction
CC       downstream of the ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4 receptors,
CC       playing a positive role in 'outside-in' signaling and granule secretion
CC       signal transduction. May relay signals from the activated ITGA2B
CC       receptor by regulating the uncoupling of WASP and WIPF1, thereby
CC       permitting the regulation of actin filament nucleation and branching
CC       activity of the Arp2/3 complex. May mediate inhibitory effects of free
CC       fatty acids on insulin signaling by phosphorylating IRS1, which in turn
CC       blocks IRS1 tyrosine phosphorylation and downstream activation of the
CC       PI3K/AKT pathway. Phosphorylates MSN (moesin) in the presence of
CC       phosphatidylglycerol or phosphatidylinositol (By similarity).
CC       Phosphorylates PDPK1 at 'Ser-504' and 'Ser-532' and negatively
CC       regulates its ability to phosphorylate PKB/AKT1 (By similarity).
CC       Phosphorylates CCDC88A/GIV and inhibits its guanine nucleotide exchange
CC       factor activity (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q04759, ECO:0000269|PubMed:9516463}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC         Evidence={ECO:0000250|UniProtKB:Q04759};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.13;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ACTIVITY REGULATION: Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are
CC       calcium-insensitive, but activated by diacylglycerol (DAG) and
CC       phosphatidylserine. Three specific sites; Thr-538 (activation loop of
CC       the kinase domain), Ser-676 (turn motif) and Ser-695 (hydrophobic
CC       region), need to be phosphorylated for its full activation (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Part of a membrane raft complex composed at least of BCL10,
CC       CARD11, MALT1 and IKBKB (By similarity). Interacts with GLRX3 (via N-
CC       terminus) (PubMed:18479680). Interacts with ECT2 (By similarity).
CC       Interacts with CCDC88A/GIV; the interaction leads to phosphorylation of
CC       CCDC88A and inhibition of its guanine nucleotide exchange factor
CC       activity (By similarity). {ECO:0000250|UniProtKB:Q04759,
CC       ECO:0000269|PubMed:18479680}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}; Peripheral membrane protein. Note=In resting T-cells,
CC       mostly localized in cytoplasm. In response to TCR stimulation,
CC       associates with lipid rafts and then localizes in the immunological
CC       synapse (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The C1 domain, containing the phorbol ester/DAG-type region 1
CC       (C1A) and 2 (C1B), is the diacylglycerol sensor and the C2 domain is a
CC       non-calcium binding domain.
CC   -!- PTM: Autophosphorylation at Thr-219 is required for targeting to the
CC       TCR and cellular function of PRKCQ upon antigen receptor ligation.
CC       Following TCR stimulation, phosphorylated at Tyr-90 and Ser-685 (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03106275; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03107517; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03106934; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03106283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03107733; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03106804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03108584; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03106764; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB020614; BAA78371.1; -; mRNA.
DR   SMR; Q9WTQ0; -.
DR   IntAct; Q9WTQ0; 2.
DR   STRING; 10116.ENSRNOP00000025902; -.
DR   BindingDB; Q9WTQ0; -.
DR   ChEMBL; CHEMBL2094266; -.
DR   DrugCentral; Q9WTQ0; -.
DR   iPTMnet; Q9WTQ0; -.
DR   PhosphoSitePlus; Q9WTQ0; -.
DR   PaxDb; Q9WTQ0; -.
DR   PRIDE; Q9WTQ0; -.
DR   UCSC; RGD:620968; rat.
DR   RGD; 620968; Prkcq.
DR   eggNOG; KOG0694; Eukaryota.
DR   InParanoid; Q9WTQ0; -.
DR   PhylomeDB; Q9WTQ0; -.
DR   Reactome; R-RNO-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-RNO-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-RNO-202424; Downstream TCR signaling.
DR   Reactome; R-RNO-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-RNO-373752; Netrin-1 signaling.
DR   Reactome; R-RNO-9648002; RAS processing.
DR   PRO; PR:Q9WTQ0; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0001772; C:immunological synapse; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004698; F:calcium-dependent protein kinase C activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004697; F:protein kinase C activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0106311; F:protein threonine kinase activity; IEA:RHEA.
DR   GO; GO:0007568; P:aging; IEP:RGD.
DR   GO; GO:0060326; P:cell chemotaxis; ISO:RGD.
DR   GO; GO:0002376; P:immune system process; IEA:UniProtKB-KW.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:RGD.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISO:RGD.
DR   GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0070233; P:negative regulation of T cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; IEP:RGD.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; IMP:RGD.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; ISS:UniProtKB.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 production; ISO:RGD.
DR   GO; GO:0032753; P:positive regulation of interleukin-4 production; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; IMP:RGD.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IDA:RGD.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IMP:RGD.
DR   GO; GO:0050870; P:positive regulation of T cell activation; ISS:UniProtKB.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; ISO:RGD.
DR   GO; GO:2000318; P:positive regulation of T-helper 17 type immune response; ISS:UniProtKB.
DR   GO; GO:2000570; P:positive regulation of T-helper 2 cell activation; ISS:UniProtKB.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; ISO:RGD.
DR   GO; GO:1904355; P:positive regulation of telomere capping; ISO:RGD.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; ISO:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; ISO:RGD.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IMP:RGD.
DR   GO; GO:0090330; P:regulation of platelet aggregation; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0019229; P:regulation of vasoconstriction; IEP:RGD.
DR   GO; GO:0045730; P:respiratory burst; IEP:RGD.
DR   GO; GO:0009749; P:response to glucose; IEP:RGD.
DR   GO; GO:0009408; P:response to heat; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0042246; P:tissue regeneration; IEP:RGD.
DR   CDD; cd00029; C1; 2.
DR   CDD; cd05619; STKc_nPKC_theta; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR034668; nPKC_theta.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR027264; PKC_theta.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR014376; Prot_kin_PKC_delta.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000551; PKC_delta; 1.
DR   PIRSF; PIRSF501105; Protein_kin_C_theta; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Cytoplasm; Immunity; Inflammatory response;
KW   Kinase; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   CHAIN           1..707
FT                   /note="Protein kinase C theta type"
FT                   /id="PRO_0000270836"
FT   DOMAIN          1..107
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          380..634
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          635..706
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   ZN_FING         159..209
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         231..281
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   NP_BIND         386..394
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        504
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         409
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         90
FT                   /note="Phosphotyrosine; by LCK"
FT                   /evidence="ECO:0000250|UniProtKB:Q04759"
FT   MOD_RES         219
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q04759"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q04759"
FT   MOD_RES         538
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q04759"
FT   MOD_RES         676
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         685
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q04759"
FT   MOD_RES         695
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q04759, ECO:0000255"
SQ   SEQUENCE   707 AA;  81750 MW;  7F82E35DE0C09DB9 CRC64;
     MSPFLRIGLS NFDCGTCQAC QGEAVNPYCA VLVKEYVESE NGQMYIQKKP TMYPPWDSTF
     DAHINKGRVM QIIVKGKNVD LISETTVELY SLAERCRKNN GRTEIWLELK PQGRMLMNAR
     YFLEMSDTKD MSEFENEGFF ALHHRRGAIK QAKVHHVKCH EFTATFFPQP TFCSVCHEFV
     WGLNKQGYQC RRCNAAIHKK CIDKVIAKCT GSAINSRETM FHKERFKIDM PHRFKVYNYK
     SPTFCEHCGT LLWGLARQGL KCDACGMNVH HRCQTKVANL CGINQKLMAE ALAMIESTQQ
     ARTLRDSEHI FREGPIEISF PRSIKSETRP PCVPTPGKSE PQGICWESPL DGADKTAQPP
     EPEVNLQRAS LQLKLKIDDF ILHKMLGKGS FGKVFLAEFK RTKQFFAIKA LKKDVVLMDD
     DVECTMVEKR VLSLAWEHPF LTHMFCTFQT KENLFFVMEY LNGGDLMYHI QSCHKFDLSR
     ATFYAAEVIL GLQFLHSKGI VYRDLKLDNI LLDRDGHIKI ADFGMCKENM LGDAKTNTFC
     GTPDYIAPEI LLGQKYNHSV DWWSFGVLLY EMLIGQSPFH GQDEEELFHS IRMDNPFYPR
     WLEREAKDLL VKLFVREPEK RLGVRGDIRQ HPLFREINWE ELERKEIDPP FRPKVKSPYD
     CSNFDKEFLS EKPRLSFADR ALINSMDQNM FSNFSFINPG METLICS
//
